OTC · Financial Statements
BerGenBio ASA (BRRGF) Financial Statements
$97.09
OTC: BRRGF
Market Cap $9.49B
Overview Financials Dividend
BerGenBio ASA most recently reported annual revenue of $23.0M, a net loss of $155.0M. Revenue grew at an average annual rate of 87.2% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $1.0M $0 $0 $1.0M $23.0M Operating Profit $-314.0M $-306.0M $-192.0M $-151.0M $-142.0M Net Profit $-309.0M $-299.0M $-190.0M $-139.0M $-155.0M EPS $-40.36 $-38.65 $-19.95 $-11.65 $-125.02 Op Margin -40628.4% -78569.4% -54186.2% -17834.2% -615.2%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $450.0M $167.0M $174.0M $156.0M $205.0M Total Liabilities $66.0M $78.0M $47.0M $33.0M $59.0M Cash $436.0M $150.0M $156.0M $140.0M $178.0M Borrowings $2.0M $0 $0 $1.0M $4.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-303.0M $-288.0M $-225.0M $-153.0M $-126.0M Investing Cash Flow $0 $3.0M $3.0M $4.0M $0 Financing Cash Flow $-1.0M $0 $-37.0M $-9.0M $-3.0M Net Cash Flow $-285.0M $-286.0M $6.0M $-16.0M $53.0M Free Cash Flow $-303.0M $-288.0M $-225.0M $-153.0M $-126.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.57 FCF Yield -32.29% Quick Ratio 3.23 Interest Coverage -52.68 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .